Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The discussion is not about value - it’s about the market and trading. We SAW huge news and have seen it repeatedly, simultaneously witnessing how the equity trades on that news. It spikes - then tanks - and share structure is a huge part of that action. That - and tight fisted longs escaping with any cash they can get.
[color=red]
YES, .0005/.0006 SURE IS MONSTROUS!!!!
Longs will be happy to dump them off!!!! Billions and billions available!!!! Weeeeeeee! HeHeHeHeHe
Absolutely untrue!!!!! LOL. Kong’s are dumping - see share value post FDA approval. They are getting out while they can!!!! HeHeHeHeHe
Thing is, it's even gotten difficult for flippers. I expected the FDA approval run to go higher and stay there at least a day or two longer; the peak was minimal and the crash harder and faster.
What could news of a deal possibly bring if that's all we got from the FDA? The chance of new (as in long term) investors touching this with their hard earned money is just about nil. And after that, what.....?
You are correct, this will never generate enough revenue and/or profits to support the share structure. As an investment, it sure looks and smells like game over. KW will never do, or have what it takes, to make this company profitable. Complete waste of perfectly solid patents and five FDA approvals. I have really never seen anything quite like it, and hope to never see it again.
There have been hundreds of testimonials about the product posted over the years. Sadly, they are completely meaningless as related to the performance of the company.
Seriously, the product could cure cancer (or COVID-19 if you prefer); the Whelan family still wouldn't be able to properly market it or generate enough revenue to get to break-even.
Unfortunately, the sale of the company at its current levels would generate nothing for longs in terms of payback for their patient investment.
The company has little to no value other than carry forward losses and the patents. No big company would care about its production capabilities, as they could do it cheaper/better themselves. Distributorships in place haven't done squat, and the big guns have their own in place anyway. There really isn't anything worth buying outside the patents and losses.
We will agree to disagree on something being up, but time will determine that for us!
Unfortunately, all the other steps you accurately lay out have zero chance of happening, IMO. That means, deal or no deal, the performance of the stock will remain abysmal, or at the very least not nearly as profitable as it could be for shareholders - the Whelans included.
Opinion or otherwise, it's spot on and absolutely correct.
Four weeks already.....I kept thinking it was only three, but the weeks (and years) tend to bleed into each other in the land of hyperbole in which BIEL resides.
KW doesn't like it that people are holding her feet to the fire over her #180 days passing with zero results. She makes it worse with her continued arrogant disregard for shareholders.
She unprofessionally mixes her Twitter account with business and personal information, then is incensed when people call her on it. The smartest CEO decision she has made was to shut down access. Meanwhile she stopped all communication, including the twice monthly 'updates' she promised to continue. Mind you, there was nothing of real value in any of them - just fluff and predictions that never materialized.
Quickly approaching mid-May 2020.. CE Mark? Nope. Deal signed? Nope. B Braun, Mundi, the VA, NHS, international distributorships bringing in millions? Nope.
Bike riding through the hills of Maryland? Yeah, #igotthisdad